Who is sponsoring NCT03982940?

NCT03982940 is sponsored by Marc Bosiers, MD.

What drugs are being tested in NCT03982940?

Interventions in NCT03982940: BGP+ Stent Graft System as bridging stent.

What condition does NCT03982940 study?

NCT03982940 studies Thoracoabdominal Aortic Aneurysm, Without Mention of Rupture.

Is NCT03982940 still recruiting?

NCT03982940 is currently active, enrolled. Last updated 9 April 2025.

Last reviewed 2025-04-09 · How we verify

NCT03982940

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

BGP+ Stent as Bridging Stent in BEVAR

Active, enrolled NA Last updated 9 April 2025

What this trial tests

NA trial testing BGP+ Stent Graft System as bridging stent in Thoracoabdominal Aortic Aneurysm, Without Mention of Rupture in 118 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

9 September 2020

Primary endpoint
8 March 2023

31 July 2025

Quick facts

Lead sponsor	Marc Bosiers, MD
Phase	NA
Status	Active, enrolled
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	118
Start date	9 September 2020
Primary completion	8 March 2023
Estimated completion	31 July 2025
Sites	10 locations across Germany

Drugs / interventions tested

BGP+ Stent Graft System as bridging stent

Conditions studied

Thoracoabdominal Aortic Aneurysm, Without Mention of Rupture — all drugs for Thoracoabdominal Aortic Aneurysm, Without Mention of Rupture →

Sponsor

Marc Bosiers, MD

Who can join

55 and older, any sex, with Thoracoabdominal Aortic Aneurysm, Without Mention of Rupture. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this clinical investigation is to evaluate, in a controlled setting, the safety and performance of the BGP+ balloon expandable covered stent Graft System (Bentley InnoMed, Hechingen, Germany) implanted as bridging stent in BEVAR (branched endovascular aortic repair) for complex aortic aneurysms.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

GORE VIABAHN VBX Balloon-Expandable Endoprostheses as a Bridging Stent With Branched and Fenestrated Endografts in the Endovascular Treatment of Aortic Aneurysms: Protocol for a Retrospective Multicenter Registry (EMBRACE Study).
Dioni P, Wanhainen A, Budtz-Lilly J, Dias N, et al · · 2026 · PMID 41773696 · DOI 10.2196/78970

Verify or expand the search:

Other recruiting trials for Thoracoabdominal Aortic Aneurysm, Without Mention of Rupture

Currently open trials in the same condition.

NCT06332911 — Shockwave™Peripheral Intravascular Lithotripsy Balloon for Advanced Endovascular Aortic Repair · recruiting

Other Marc Bosiers, MD trials

Trials by the same sponsor.

NCT05291247 — Shockwave IVL + DES · completed
NCT03987035 — BGP Stent as Bridging Stent in FEVAR · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03982940 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Marc Bosiers, MD
Last refreshed: 9 April 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03982940.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing